top of page
it's where dermatology lives



AD biologic non-responders benefit from extended Tx
Photo by Dwxn via Wikimedia Commons New research reveals that patients with moderate-to-severe atopic dermatitis (AD) who did not...
John Evans
May 161 min read


Lebrikizumab effective in patients of skin of colour with AD
Phase III results presented during a late-breaking session at the annual meeting of the American Academy of Dermatology in San Diego,...
Allan Ryan
Mar 18, 20242 min read


Studies examine optimal topical, systemic Txs for AD
Two reviews from researchers at McMaster University in Hamilton have identified the most effective topical and systemic treatments for...
Allan Ryan
Sep 18, 20232 min read
Featured Posts




bottom of page